NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

Truong Thanh Tung; HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH

NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

Truong Thanh Tung (Opfinder), HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH (Opfinder)

Abstract

The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.

Originalsprog	Engelsk
IPC	C07D277/44
Patentnummer	KR101384350 (B1)
Journaliseringsdato	14/04/2014
Land/Område	Sydkorea
Prioritetsdato	21/06/2012
Prioritetsnummer	KR20120066831 20120621
Status	Udgivet - 31 dec. 2013

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

https://worldwide.espacenet.com/publicationDetails/biblio?CC=KR&NR=101384350B1&KC=B1&FT=D

Citationsformater

Thanh Tung, T., & HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH (2013). NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT. (Patentnummer KR101384350 (B1)). https://worldwide.espacenet.com/publicationDetails/biblio?CC=KR&NR=101384350B1&KC=B1&FT=D

Thanh Tung, T & HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH dec.. 31 2013, NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT, Patentnummer KR101384350 (B1). <https://worldwide.espacenet.com/publicationDetails/biblio?CC=KR&NR=101384350B1&KC=B1&FT=D>

@misc{a905469e8afa40c09ff418965bbe9553,

title = "NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT",

abstract = "The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.",

author = "{Thanh Tung}, Truong and {HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH}",

year = "2013",

month = dec,

day = "31",

language = "English",

type = "Patent",

note = "KR101384350 (B1); C07D277/44",

}

TY - PAT

T1 - NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

AU - Thanh Tung, Truong

AU - HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH

PY - 2013/12/31

Y1 - 2013/12/31

N2 - The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.

AB - The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.

M3 - Patent

M1 - KR101384350 (B1)

Y2 - 2014/04/14

ER -

NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater